- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/00 - Drugs for immunological or allergic disorders
Patent holdings for IPC class A61P 37/00
Total number of patents in this class: 8920
10-year publication summary
|
248
|
247
|
391
|
506
|
513
|
503
|
623
|
610
|
594
|
430
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
290 |
| Bristol-myers Squibb Company | 4840 |
144 |
| F. Hoffmann-La Roche AG | 7946 |
134 |
| Novartis AG | 10707 |
120 |
| Genentech, Inc. | 4012 |
75 |
| Incyte Corporation | 1029 |
74 |
| Hoffmann-La Roche Inc. | 3489 |
61 |
| Boehringer Ingelheim International GmbH | 4644 |
60 |
| Merck Patent GmbH | 5764 |
52 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
48 |
| Glaxo Group Limited | 4132 |
43 |
| Takeda Pharmaceutical Company Limited | 2704 |
42 |
| Janssen Pharmaceutica N.V. | 3367 |
41 |
| Glaxosmithkline Intellectual Property Development Limited | 768 |
40 |
| The Regents of the University of California | 20153 |
39 |
| AstraZeneca AB | 2872 |
39 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 648 |
38 |
| Jiangsu Hengrui Medicine Co., Ltd. | 708 |
34 |
| Bayer Pharma AG | 1054 |
33 |
| Pfizer Inc. | 3396 |
32 |
| Other owners | 7481 |